Immutep (acquired) Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Immutep (acquired) General Information

Description

Developer of targeted protein-based immunotherapeutics in oncology. The company offers immu-fact, an antigen presenting cell activator for amplifying the T cell response and ImmuCcine, an human protein immunostimulatory factor for the treatment of cancer and vectorisation of T-cell antigens.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Parc Club Orsay, 2
  • rue Jean Rostand
  • 91893 Orsay
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Parc Club Orsay, 2
  • rue Jean Rostand
  • 91893 Orsay
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immutep (acquired) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immutep (acquired)‘s full profile, request access.

Request a free trial

Immutep (acquired) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immutep (acquired) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immutep (acquired)‘s full profile, request access.

Request a free trial

Immutep (acquired) FAQs

  • When was Immutep (acquired) founded?

    Immutep (acquired) was founded in 2001.

  • Where is Immutep (acquired) headquartered?

    Immutep (acquired) is headquartered in Orsay, France.

  • What is the size of Immutep (acquired)?

    Immutep (acquired) has 11 total employees.

  • What industry is Immutep (acquired) in?

    Immutep (acquired)’s primary industry is Drug Discovery.

  • Is Immutep (acquired) a private or public company?

    Immutep (acquired) is a Private company.

  • What is the current valuation of Immutep (acquired)?

    The current valuation of Immutep (acquired) is .

  • What is Immutep (acquired)’s current revenue?

    The current revenue for Immutep (acquired) is .

  • How much funding has Immutep (acquired) raised over time?

    Immutep (acquired) has raised $6.38M.

  • Who are Immutep (acquired)’s investors?

    Equitis Gestion, IPSA( Asset Management), and Idinvest Partners have invested in Immutep (acquired).

  • When was Immutep (acquired) acquired?

    Immutep (acquired) was acquired on 17-Dec-2014.

  • Who acquired Immutep (acquired)?

    Immutep (acquired) was acquired by Immutep.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process